Menergy NAD+

Product Details

What Is Menergy NAD+?

Menergy NAD+ is a prescription injectable NAD+ treatment intended for eligible adults seeking clinician-guided support for energy, focus, physical recovery, performance, and healthy aging. It contains nicotinamide adenine dinucleotide and is administered by subcutaneous injection at home according to a personalized treatment plan.

The program includes an online medical assessment, clinician review, individualized dosing instructions, prescription medication, injection supplies, cold-chain delivery, and ongoing medical support. These uses reflect how Menergy markets the therapy and should not be interpreted as guaranteed clinical outcomes.

Who May Consider Menergy NAD+?

Adults interested in medically supervised injectable NAD+ therapy may consider the program if they prefer telehealth assessment and home administration rather than visiting a clinic for infusions. Menergy requires platform users to be at least 21 years old and located in a participating U.S. state.

Clinical eligibility is determined individually. Persistent fatigue, cognitive changes, sleep problems, unexplained weakness, or other ongoing symptoms should receive appropriate medical evaluation because such symptoms can have many causes unrelated to NAD+ levels.

How May Menergy NAD+ Support General Wellness?

NAD+ is a naturally occurring coenzyme involved in cellular oxidation-reduction reactions, energy metabolism, mitochondrial processes, DNA-related pathways, and cellular signaling. These established biological roles explain the research interest in strategies intended to modify NAD+ availability.

However, the biological importance of NAD+ does not establish that injectable NAD+ produces specific wellness or anti-aging results. A 2026 systematic review found that clinical effectiveness for NAD-related anti-aging and wellness interventions remains inconclusive, with particularly limited outcomes evidence for direct parenteral NAD+.

Prescription Formulation

Menergy’s current public website identifies the therapy as injectable NAD+ but does not publish the exact concentration or universal dose.

Patients should follow their prescription and pharmacy instructions rather than relying on general NAD+ dosing information found online.

Active Component

• Nicotinamide Adenine Dinucleotide (NAD+)

NAD+ is a coenzyme naturally present in human cells. It participates in energy metabolism, redox reactions and several signaling pathways involving cellular maintenance and metabolic regulation.

Research involving oral NAD+ precursors such as nicotinamide riboside and nicotinamide mononucleotide is considerably more extensive than research involving direct injectable NAD+. Results from precursor studies should therefore not automatically be applied to Menergy’s injectable formulation.

Potential Benefits

• May support normal cellular metabolism: NAD+ participates in essential metabolic and redox reactions.
• Provides direct injectable administration: The program uses a subcutaneous injectable format rather than an oral supplement.
• Provides individualized medical oversight: A licensed clinician reviews the patient’s health information before treatment.
• Includes home treatment supplies: Approved patients receive the injection supplies needed for the prescribed protocol.
• Provides ongoing clinical support: Menergy includes continued clinician support as part of its monthly program.

Claims relating to increased energy, improved focus, faster recovery, sleep, sexual performance, or anti-aging are promoted by Menergy but are not established outcomes for every patient.

Important Limitations

• Clinical outcomes evidence for direct injectable NAD+ remains limited.
• Evidence involving oral NR or NMN cannot automatically be applied to injected NAD+.
• The exact public NAD+ concentration and standardized dose are not displayed.
• Treatment requires clinician approval and is available only in participating states.
• Individual response and tolerance can vary considerably.

A 2026 systematic review identified no eligible clinical outcomes trials evaluating intravenous or intramuscular NAD+ itself for anti-aging or general wellness outcomes. The authors concluded that better randomized trials are needed for parenteral approaches.

How To Use?

1. Complete Menergy’s online health assessment.
2. Provide accurate medical history, medication, and health information.
3. A licensed clinician reviews the information and determines eligibility.
4. If approved, the prescribed injectable NAD+ and supplies are shipped on ice.
5. Administer the subcutaneous injection only according to the dose, frequency, technique, storage conditions, and instructions supplied by the clinician and pharmacy.

Menergy states that the package includes 31-gauge needles. The public site does not provide one standard dose or frequency because the treatment protocol is individualized.

Warnings And Precautions

• Use injectable NAD+ only after evaluation by a qualified healthcare professional.
• Tell the clinician about all prescription medicines, OTC products, vitamins, and supplements.
• Disclose existing medical conditions and previous significant reactions to medications or injections.
• Discuss pregnancy, plans for pregnancy, or breastfeeding with the clinician when applicable.
• Follow the pharmacy’s refrigeration, storage, and handling instructions.
• Use sterile injection supplies and never share needles, syringes, or medication.
• Contact the clinical team if an unexpected or persistent reaction develops.
• Seek urgent medical care for severe allergic reactions, breathing difficulty, fainting, or other serious symptoms.

Possible Side Effects And Interactions

Menergy states that some users may experience brief lightheadedness or warmth following an injection. Individual tolerance may differ, and systematic safety information for direct subcutaneous NAD+ therapy remains limited compared with more extensively studied medicines.

Patients should discuss their full medication and medical history with the prescribing clinician. Unexpected reactions should be reported rather than managed by changing the dose or injection frequency without medical guidance.

Pharmacy And Quality Information

Menergy states that its injectable NAD+ comes from licensed U.S. compounding pharmacies. Medication is shipped directly to approved patients using cold-chain delivery.

Menergy Meds itself does not manufacture medication. Its Terms of Service state that medications available through the platform are dispensed by independent licensed third-party pharmacies.

The public page does not identify one universal dispensing pharmacy because pharmacy selection can depend on prescription and location.

Pros

• Licensed clinician review is required.
• Individualized prescription protocol is included.
• Subcutaneous home administration avoids clinic visits.
• Injection supplies are provided with treatment.
• Free cold-chain delivery is currently advertised.

Cons

• Clinical evidence for injectable NAD+ wellness outcomes remains limited.
• Treatment requires injections and proper sterile technique.
• Exact concentration and dose are not publicly standardized.
• Service availability depends on state and clinical eligibility.
• Completed purchases are subject to a no-refund policy.

Pricing And Subscription Information

Menergy NAD+ is currently offered as a monthly telehealth subscription that includes clinician review, prescribed injectable NAD+, injection supplies, cold-chain delivery, and ongoing medical support for eligible adults.

• Menergy NAD+ pricing starts at: $199

Menergy states that patients are not charged until a clinician reviews and approves the protocol. The $199 monthly price includes clinician support, prescription treatment, supplies, and shipping.

The Medical Consent states that programs automatically renew and continue charging the payment method unless canceled before the next processing date. It also states that there are no refunds or exchanges and all sales are final.

Pharmacist Note

Injectable NAD+ should be used only under the individualized prescription provided by the clinician and pharmacy. Review medications, medical conditions, storage requirements, injection technique, and sterile handling before beginning therapy. Do not independently increase the dose or injection frequency.

FAQ

1. What exactly is Menergy NAD+?

Menergy NAD+ is a telehealth program providing clinician-prescribed injectable nicotinamide adenine dinucleotide. Eligible patients receive medical review, an individualized protocol, injection supplies, cold-chain home delivery, and ongoing clinical support.

2. Does Menergy NAD+ require a prescription?

Yes. A licensed healthcare professional must review the patient’s health information and determine that treatment is appropriate. Menergy states that patients are not charged until the clinician reviews and approves the protocol.

3. How is Menergy NAD+ administered?

The current program uses subcutaneous injections with 31-gauge needles. Patients should follow the exact dose, frequency, injection technique, and storage instructions supplied by their prescribing clinician and dispensing pharmacy.

4. Is injectable NAD+ proven for anti-aging?

Current clinical evidence is limited. A 2026 systematic review concluded that effectiveness of NAD-related interventions for anti-aging and wellness remains inconclusive and identified a lack of clinical outcomes trials for direct parenteral NAD+.

5. How much does Menergy NAD+ cost?

The current advertised price is $199 per month. The subscription includes clinician oversight, an individualized protocol, injectable NAD+, injection supplies, free cold-chain shipping, and ongoing clinical support.

6. Can the Menergy NAD+ subscription be canceled?

Yes. Menergy advertises cancellation without a long-term contract. However, programs automatically renew until canceled before the next processing date, and completed sales are final with no refunds or exchanges.

Medical Disclaimer

This information is provided for general educational purposes and does not replace individualized medical advice, diagnosis, prescribing instructions, or pharmacy guidance. Injectable NAD+ should be used only after evaluation by a qualified healthcare professional and according to the prescribed treatment protocol.

Sources And Product Review Information

• Official website: Menergy NAD+
• Menergy Terms & Conditions
• Menergy Telehealth and Medical Consent

Affiliate Disclosure: This page may include affiliate links. We may earn a commission if you purchase through these links, at no extra cost to you. Our content remains independent and is based on publicly available product, label, and manufacturer information.